RUSSO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 510
EU - Europa 363
AS - Asia 142
AF - Africa 10
SA - Sud America 2
Totale 1.027
Nazione #
US - Stati Uniti d'America 508
IT - Italia 232
SG - Singapore 110
DE - Germania 47
FI - Finlandia 17
NL - Olanda 15
ES - Italia 14
GB - Regno Unito 13
CN - Cina 12
IN - India 8
UA - Ucraina 8
CI - Costa d'Avorio 7
IE - Irlanda 6
JP - Giappone 4
BE - Belgio 3
FR - Francia 3
PK - Pakistan 3
RU - Federazione Russa 3
BR - Brasile 2
CA - Canada 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
NP - Nepal 1
RO - Romania 1
SC - Seychelles 1
VN - Vietnam 1
Totale 1.027
Città #
Chandler 113
Singapore 92
Santa Clara 55
Naples 42
Milan 30
Ashburn 26
Rome 22
Lawrence 20
Des Moines 15
Helsinki 15
Millbury 15
Amsterdam 11
Boston 10
Bologna 9
Valencia 9
Florence 8
Munich 8
Wilmington 8
Krefeld 7
Genoa 5
Cilavegna 4
Council Bluffs 4
London 4
Los Angeles 4
Sciacca 4
Bad Durrheim 3
Bari 3
Berlin 3
Casalnuovo di Napoli 3
Dublin 3
Fairfield 3
Fisciano 3
Grosseto 3
Houston 3
Karachi 3
Kronberg 3
Montalto di Castro 3
Napoli 3
Pamplona 3
Pune 3
Salt Lake City 3
Seattle 3
Venaria Reale 3
Agrate Brianza 2
Atlanta 2
Brindisi 2
Cagliari 2
Castellammare Di Stabia 2
Cava Manara 2
Dragoni 2
Falkenstein 2
Ferrara 2
Foggia 2
Lappeenranta 2
Monza 2
New York 2
Norwalk 2
Pagani 2
Qualiano 2
Shanghai 2
São Paulo 2
Tokyo 2
Woodbridge 2
Alatri 1
Almaty 1
Angri 1
Antwerp 1
Athens 1
Avellino 1
Bad Bellingen 1
Beijing 1
Boardman 1
Brussels 1
Campobasso 1
Castelforte 1
Chennai 1
Clifton 1
Davis 1
Ercolano 1
Fiuggi 1
Formia 1
Frankfurt am Main 1
Fuzhou 1
Galati 1
Gavirate 1
Genazzano 1
Greve in Chianti 1
Grezzana 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Hong Kong 1
Huizhou 1
Kagoya 1
Kathmandu 1
Madrid 1
Monterrey 1
Moscow 1
Paris 1
Pasadena 1
Totale 671
Nome #
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 85
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 47
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 44
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 41
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 41
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 39
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 38
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 37
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 35
Brca1/2 ngs somatic testing in clinical practice: a short report 35
Methods for actionable gene fusion detection in lung cancer: now and in the future 33
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 32
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 31
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 31
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 29
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 28
Critical aspects of MSI testing in endometrial cancer: a comparison study 28
BRAF: A Two-Faced Janus 28
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 28
Next generation sequencing in cytology 28
The role of liquid biopsy in epithelial ovarian cancer: state of the art 26
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 25
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 25
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 25
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 24
Tumor mutational burden on cytological samples: A pilot study 23
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 22
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 22
The evolving role of liquid biopsy in lung cancer 21
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 21
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 20
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 19
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 17
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 11
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 8
The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study 8
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 7
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 6
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 4
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 4
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma 4
Totale 1.080
Categoria #
all - tutte 6.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 11 5 12 7 9 6 6
2021/2022173 6 5 12 2 3 3 3 15 1 25 55 43
2022/2023300 26 14 17 12 46 41 1 34 45 20 41 3
2023/2024301 10 42 17 16 20 18 13 34 17 33 40 41
2024/2025250 54 58 6 17 38 77 0 0 0 0 0 0
Totale 1.080